The Anti-aging and Disease Prevention Tour, a large non-profit community outreach campaign organized by China Anti-aging Promoting Association (CAPA) and hosted by CAPA Integrative Medicine Committee jointly with Lei Yunshang Pharmaceutical and other 11 other China’s top 100 pharmaceutical retail chain enterprises was kicked off on June 16, 2015 at the “Taoist Shrine” Mount Wudang in Hubei.
As CGE Healthcare’s core platform for modern Chinese medicine, Lei Yunshang Pharmaceutical Group has nearly 300 years of history. It owns a number of state-classified formula and state-protected TCM in oncology, cardiovascular diseases, liver diseases, kidney diseases, etc. The campaign purpose is to raise awareness about self-care and disease prevention among the general public in a bid to reduce chronic diseases and improve health for longevity, and to integrate and optimize social resource allocation for a sustainable economic development of the nation.
(CAPA Executive VP & Secretary-General Liu Renfu presents Lei Yunshang Pharmaceutical Group with the Integrative Medicine Committee plaque)
Liu Renfu, CAPA Executive VP & Secretary-General, and former news director of Ministry of Health, announced the Integrative Medicine Committee, championed by Lei Yunshang Pharmaceutical, was officially formed, and “The 2015 Anti-aging and Disease Prevention Tour of China” was officially launched. Zhang Lixue, the GM of Lei Yunshang Pharmaceutical, was appointed chairman of the Integrative Medicine Committee. Lei Yunshang Pharmaceutical and 11 others of China’s top 100 pharmaceutical retail chain enterprises received CAPA membership plaques and were authorized to participate in this public campaign.
(11 of China’s top 100 pharmaceutical retail chain enterprises were granted CAPA memberships)
It is reported that the Anti-aging and Disease Prevention campaign will cover 110 communities in 10 cities. The campaign will focus on publicizing “Anti-aging and disease prevention” concepts and raise awareness of good self-care and disease prevention among the residents. Through free healthcare lectures and workshops, free brochures and Longevity Boxing Tournament, the campaign will educate large populations about healthy living and promote healthy lifestyles. The organizers will establish Anti-aging and Disease Prevention Fund and raise money through charity sales of healthcare products to provide financial assistance to elderly patients with chronic diseases, and raise awareness of caring people with chronic diseases.
In recent years, Lei Yunshang Pharmaceutical Group has been committed to anti-aging and disease prevention research, and TCM cultural inheritance. The company has actively responded to nationwide health campaign called for by Chinese Minister of Health, implemented a comprehensive anti-aging strategy, and devoted to the industrial development of Anti-aging and Disease Prevention. Going forward, Lei Yunshang will continue to work with others to integrate and optimize the allocation of social resources for the establishment of anti-aging and chronic disease prevention service system, and devote to anti-aging industry growth for China’s “health dream”.
(In alignment with “integrative medicine for anti-aging and disease prevention”, Lei Yunshang Pharmaceutical Group invited WuDang Taoist priest Wu Wei Zi, to devise Chinese Longevity Boxing for anti-aging and disease prevention purposes and teach the Chinese Longevity Boxing techniques)
LATEST NEWS
Grand Pharma brings heavyweight products to the World Health Expo
2023-04-12
Grand Pharma Recognized as a National Technology Innovation Demonstration Enterprise
2022-11-09
Globally innovative products Atectura® and Enerzair® developed by Grand Pharma officially enter the domestic market
2022-09-06
Accelerating Global Innovation, Opening Ceremony of Grand Pharma Optics Valley R&D Center and Extensive Intervention Production and R&D Platform
2022-08-24
SIR-Spheres® Yttrium-90 Microspheres Injections Introduced by Grandpharma Officially Launched in Chinese Market
2022-06-22
Yuanda Shuyang's New Production Base for Blood Products Officially Put into Operation
2022-04-15